Page 1,884«..1020..1,8831,8841,8851,886..1,8901,900..»

Bone stem cells shown to regenerate bones, cartilage in adult mice

Posted: January 17, 2015 at 9:50 am

A stem cell capable of regenerating both bone and cartilage has been identified in bone marrow of mice. The discovery by researchers at Columbia University Medical Center (CUMC) is reported today in the online issue of the journal Cell.

The cells, called osteochondroreticular (OCR) stem cells, were discovered by tracking a protein expressed by the cells. Using this marker, the researchers found that OCR cells self-renew and generate key bone and cartilage cells, including osteoblasts and chondrocytes. Researchers also showed that OCR stem cells, when transplanted to a fracture site, contribute to bone repair.

"We are now trying to figure out whether we can persuade these cells to specifically regenerate after injury. If you make a fracture in the mouse, these cells will come alive again, generate both bone and cartilage in the mouse--and repair the fracture. The question is, could this happen in humans," says Siddhartha Mukherjee, MD, PhD, assistant professor of medicine at CUMC and a senior author of the study.

The researchers believe that OCR stem cells will be found in human bone tissue, as mice and humans have similar bone biology. Further study could provide greater understanding of how to prevent and treat osteoporosis, osteoarthritis, or bone fractures.

"Our findings raise the possibility that drugs or other therapies can be developed to stimulate the production of OCR stem cells and improve the body's ability to repair bone injury--a process that declines significantly in old age," says Timothy C. Wang, MD, the Dorothy L. and Daniel H. Silberberg Professor of Medicine at CUMC, who initiated this research. Previously, Dr. Wang found an analogous stem cell in the intestinal tract and observed that it was also abundant in the bone.

"These cells are particularly active during development, but they also increase in number in adulthood after bone injury," says Gerard Karsenty, MD, PhD, the Paul A. Marks Professor of Genetics and Development, chair of the Department of Genetics & Development, and a member of the research team.

The study also showed that the adult OCRs are distinct from mesenchymal stem cells (MSCs), which play a role in bone generation during development and adulthood. Researchers presumed that MSCs were the origin of all bone, cartilage, and fat, but recent studies have shown that these cells do not generate young bone and cartilage. The CUMC study suggests that OCR stem cells actually fill this function and that both OCR stems cells and MSCs contribute to bone maintenance and repair in adults.

The researchers also suspect that OCR cells may play a role in soft tissue cancers.

Story Source:

The above story is based on materials provided by Columbia University Medical Center. Note: Materials may be edited for content and length.

Here is the original post:
Bone stem cells shown to regenerate bones, cartilage in adult mice

Posted in Stem Cells | Comments Off on Bone stem cells shown to regenerate bones, cartilage in adult mice

Bone stem cells may regenerate bones and cartilage

Posted: January 17, 2015 at 9:50 am

New York, Jan 16 (IANS): Indian-American researcher Siddhartha Mukherjee from Columbia University Medical Center (CUMC) has identified stem cells that are capable of regenerating both bone and cartilage in bone marrow of mice.

The cells called osteochondroreticular (OCR) stem cells were discovered by tracking a protein expressed by the cells.

Using this marker, Mukherjee and his team found that OCR cells self-renew and generate key bone and cartilage cells.

The team also showed that OCR stem cells, when transplanted to a fracture site, contribute to bone repair.

The researchers believe OCR stem cells are present in human bone tissue as mice and humans have similar bone biology.

"If you make a fracture in the mouse, these cells will come alive again, generate both bone and cartilage in the mouse and repair the fracture. The question is, could this happen in humans," asked Mukherjee, assistant professor of medicine.

Further study could provide greater understanding of how to prevent and treat osteoporosis, osteoarthritis or bone fractures.

The researchers also suspect that OCR cells may play a role in soft tissue cancers.

The paper was reported online in the journal Cell.

The rest is here:
Bone stem cells may regenerate bones and cartilage

Posted in Stem Cells | Comments Off on Bone stem cells may regenerate bones and cartilage

Bone Stem Cells Regenerate Bone, Cartilage in Mice

Posted: January 17, 2015 at 9:50 am

Osteoarthritis is a common condition seen in older people in which the tissue between joints becomes worn down, causing severe pain. In what could be an important development for people who suffer from it, U.S. researchers have isolated stem cells in adult mice that regenerate both worn tissue, or cartilage, and bone.

For the past decade, researchers have been trying to locate and isolate stem cells in the spongy tissue or marrow of bones of experimental animals.

x

The so-called osteochondroreticular, or OCR, cells are capable of renewing and generating important bone and cartilage cells.

Researchers at Columbia University Medical Center in New York identified these master cells in the marrow. When grown in the lab and transplanted back into a fracture site in mice, they helped repair the broken bones.

Siddhartha Mukherjee, the study's senior author, said similar stem cells exist in the human skeletal system.

The real provocative experiment or the provocative idea is being able to do this in humans being able to extract out these stem cells from humans and being able to put them back in to repair complex fracture defects or osteoarthritis defects, said Mukherjee.

He noted that children have more bone stem cells than adults, which may explain why the bones of young people repair more easily than fractures in adults.

Mukherjee said the next step is to try to identify the OCR cells in humans and attempt to use them to repair complex bone and cartilage injuries.

Once cartilage is injured or destroyed in older people, as in osteoarthritis, Mukherjee said it does not repair itself.

Read the rest here:
Bone Stem Cells Regenerate Bone, Cartilage in Mice

Posted in Stem Cells | Comments Off on Bone Stem Cells Regenerate Bone, Cartilage in Mice

Eminent Clinician and Scientist in Oncology, Hematology, and Regenerative Medicine, David K. Jin, MD, PhD, Inducted …

Posted: January 17, 2015 at 9:50 am

New York, New York (PRWEB) January 16, 2015

The Leading Physicians of the World and the International Association of HealthCare Professionals are proud to announce that David K. Jin, MD, PhD, is being honored for his exceptional successes as a clinical-scientist in oncology, hematology, and regenerative medicine. Over his many years in practice, Dr. Jin has continued to demonstrate the passion, dedication, and enthusiasm for patient care necessary to be considered a Top Clinician, Scientist, and Researcher in his field.

Dr. Jin is currently the Chief Medical Officer of BioTime Inc. as well as its subsidiary OncoCyte Corporation and BioTime Asia Limited. His passion has been to develop novel products for the treatment and diagnosis based on stem cell-derived technology in order to improve both the quality and length of life of patients. Dr. Jin is a clinician and a scientist dedicated to the fields of oncology, hematology, regenerative medicine, and cancer immunotherapy. His work includes his role in various regulatory agencies internationally as medical reviewers as well as Chief Consultant and Advisor for various biotechnology and pharmaceutical companies regarding hematology, oncology, and stem cell-based technology development. Dr. Jin is also a published author and co-author with more than 80 peer reviewed articles, scientific abstracts, reviews, and book chapters featured in publications such as Nature, Nature Medicine, Cell, PNAH, and JCI. He was formerly affiliated with New York-Presbyterian Hospital-Ansary Stem Cell Institute.

Dr. Jin studied medicine at SUNY Downstate Medical Centers College of Medicine in Brooklyn, New York. Established 140 years ago, the school truly revolutionized medical education in the United States as the first medical school founded within a hospital, making bedside training an integral part of students' education. Upon his graduation in 2000, Dr. Jin pursued further clinical training, including his fellowship in hematology and oncology at NewYork-Presbyterian Hospital, where he subsequently received faculty tenure. The NewYork-Presbyterian Hospital is the teaching hospital for both Cornell and Columbia Universities in the areas of internal medicine, hematology, and clinical oncology. Moreover, Dr. Jin has been senior translational scientist at the Howard Hughes Medical Institute and the Ansary Center for Stem Cell Therapeutics at Cornell. His discovery of the chemokine-driven hemangiocytes (bone marrow-derived CXCR4- and VEGFR1-expressing hematopoietic stem cells) in 2006 has had significant impact on the understanding of stem cell mobilization, angiogenesis, and stem cell niche theory. In 2012, Dr. Jin was honored as Top Chief Medical Officer and has been principle investigator in more than 15 pre-clinical and clinical trials as well as translation researcher in stem biology, cancer, and vascular medicine.

To find out more about Dr. Jin, please visit http://www.biotimeinc.com or http://www.oncocyte.com. Also be sure to look out for his upcoming publication in The Leading Physicians of the World.

To find a Doctor by Specialty and Zip Code, please visit http://www.findatopdoc.com and book your appointment online instantly.

Link:
Eminent Clinician and Scientist in Oncology, Hematology, and Regenerative Medicine, David K. Jin, MD, PhD, Inducted ...

Posted in Regenerative Medicine | Comments Off on Eminent Clinician and Scientist in Oncology, Hematology, and Regenerative Medicine, David K. Jin, MD, PhD, Inducted …

Vet-Stem, Inc. CEO announces hiring of President and Chief Commercial Officer (Dr. Alexis Nahama).

Posted: January 17, 2015 at 9:50 am

Poway, California (PRWEB) January 16, 2015

January 16th, 2015 Leading Regenerative Veterinary Medicine company, Vet-Stem, Inc., CEO announced the hiring of President and Chief Commercial Officer, Alexis Nahama, DVM.

After ten years of market presence, serving early adopter and progressive veterinarians, we are ready to take our company to the next level. We are heavy on science, and have engaged in the development of our next generation of therapeutic solutions, including working with the FDA towards obtaining approval for the first veterinary cellular therapy product to be used in helping dogs affected by osteoarthritis. In addition to its aim of reducing the pain of osteoarthritis, this therapy has the potential to impact the progression of the disease, and to promote tissue regeneration. Given the complexities of such developments, I have decided to focus most of my time to our research programs. I needed a great partner to take on the current operations and focus our commercial approach, said Dr Bob Harman (CEO).

Dr. Harman and the board of directors announced the appointment of Dr. Alexis Nahama as the new Vet-Stem, Inc.s President and Chief Commercial Officer.

Dr. Nahama, former head of marketing for VCA Inc. (Nasdaq: Woof), brings two decades of global veterinary industry experience with him, ranging from clinical development to managing some of the most influential brands in animal health.

Our current technology has helped over 10,000 dogs, horses and cats through processing of their own fat tissue to extract stem cells that are then injected in painful joints, tendons or ligaments, but many owners are still unaware we have a possible solution for their animals need. Although not inexpensive, (great breakthrough technologies seldom are) this therapeutic approach is already available through many veterinarians today! said Dr Nahama.

Vet-Stem Inc., despite its relatively small size has the potential to dramatically change the way veterinarians address difficult diseases in the not so distant future. In a world of giant corporations, this company will be truly disruptive and benefit countless patients worldwide. It is with great pride and excitement that I take on these responsibilities and join this amazingly smart and dedicated group of people,added Dr. Nahama.

Alexis passion for helping pet owners and veterinarians, coupled with his extensive knowledge of the veterinary industry and his marketing expertise, is exactly what we need to succeed, stated Dr. Harman. I am happy to welcome him to be part of our leadership team.

About Vet-Stem, Inc. Vet-Stem, Inc. was formed in 2002 to bring regenerative medicine to the veterinary profession. This privately held biotechnology enterprise, based near San Diego (California), currently offers veterinarians access to stem-cell therapy (extracted from the patients own fat tissue), among other regenerative treatment modalities. With over 10,000 patients treated by veterinarians for joint, tendons and ligament issues, Vet-Stem has made regenerative medicine applications a therapeutic reality beyond the realm of research. Development programs focused on products and services that utilize the natural tissue healing properties inherent in all living creatures, have the potential to dramatically improve the quality of life for our animals Vet-Stems progress in bringing practical and affordable medical solutions to market might change animal lives by improving the quality of recovery in acute conditions, but also by unlocking ways to slow, stop and ultimately revert the course of chronic diseases.. Vet-Stem currently holds the exclusive licenses to over 55 patents including worldwide veterinary rights for use of adipose derived stem cells, with over 75 patents pending.

12860 Danielson Court, Suite B Poway, CA 92064 858-748-2004

Read the rest here:
Vet-Stem, Inc. CEO announces hiring of President and Chief Commercial Officer (Dr. Alexis Nahama).

Posted in Regenerative Medicine | Comments Off on Vet-Stem, Inc. CEO announces hiring of President and Chief Commercial Officer (Dr. Alexis Nahama).

Dr Sherif Stem cell therapy on OA – Video

Posted: January 17, 2015 at 9:43 am


Dr Sherif Stem cell therapy on OA
lecture powerpoint.

By: Medical Center

Link:
Dr Sherif Stem cell therapy on OA - Video

Posted in Stem Cell Therapy | Comments Off on Dr Sherif Stem cell therapy on OA – Video

We Were Promised Space Lasers: The State of the Union's Big Fibs

Posted: January 17, 2015 at 7:59 am

This Tuesday, Jan. 20, President Barack Obama will honor an American tradition as old as George Washington: the State of the Union. The constitutionally ordained address to each new session of Congress has been a presidential ritual since 1790. Its a chance to check in on the present and make some pledges for our future.

Its that future bit that got us thinking: If all that talk had come true, even the crazy, far-out pledgesespecially the crazy, far-out pledgeswhat would our world look like today? Not political promises and posturing for lower taxes or immigration reform, but lifestyle manna such as supersonic jets and paralysis-curing implants.

So we read through 35 years of State of the Union addresses, from Obama back to Ronald Reagan, and found an interesting mix of science and science fiction with varying likelihoods of the prognostications ever becoming reality. Obama may have missed his goal of having 1 million electric cars on the road by 2015 (by 725,000 cars), but its bound to happen one day. Meanwhile, Reagans nuclear shield (popularly known as the Star Wars program) is a remnant of a time tormented by the Cold War. As for Clintons child-safe smart guns well, whos to tell?

Together, these visions offer a uniquely American version of Utopia. One wed be perfectly happy driving our Wi-Fi-enabled, 3D-printed, hydrogen-fueled car aroundbut maybe only for a day or two.

The Pledge: In 2013, Obama referred to a once-shuttered warehouse in the Rust Belt that became a state-of-the-art lab where new workers are mastering 3D printing and proposed replicating its success around the country.

The Reality? As Obama said, it has already happened in Youngstown, Ohio, thanks to his Manufacturing Innovation Institutes. But the likelihood of reviving former industrial towns with 3D printing hubs seems counterintuitive to the very idea of 3D printing, not to mention the fact that 3D printing is still pricier than the old-fashioned assembly line for most manufacturers.

The Pledge:In 2013, Obama also heralded the work of scientists who are developing drugs to regenerate damaged organs and urged Congress to keep making those investments.

The Reality? Things are looking good. Scientists have made great advances in regenerating organs using stem cells (doctors grew trachea way back in 2008). And ever since Obama removed some barriers for using stem cells in research, scientists have been steaming ahead.

The Pledge: In 2000, President Bill Clinton asked gun companies to invest in smart guns to keep weapons out of the hands of children, as well as other steps to keep guns out of the wrong hands.

The Reality? Despite the 15 years that have passed since Clintons call to action, its still a dreamone pretty much destined to fail, thanks both to the National Rifle Association and to lack of consumer interest. (We do have fingerprint-enabled gun casesand GPS locators that track when a gun is drawn and shot. Baby steps.)

Read more from the original source:
We Were Promised Space Lasers: The State of the Union's Big Fibs

Posted in Ohio Stem Cells | Comments Off on We Were Promised Space Lasers: The State of the Union's Big Fibs

New Study: Turmeric Compound Activates Regeneration of …

Posted: January 17, 2015 at 7:59 am

A new study published September 26, 2014 in the Stem Cell Research & Therapy journal suggests that a component of turmeric, aromatic (ar-) turmerone, induces and increases neural stem cell proliferation.

Turmeric has been found to have numerous health benefits with especially powerful anti-inflammatory and neuroprotective properties that can improve cognitive function and neurodegenerative diseases such as Alzheimers disease. A study published back in 2012 demonstrated three months of treatment, where Alzheimers patients were given a daily turmeric supplement, resulted in a significant decrease of severe behavioral and psychological symptoms, and in two instances, patients came to recognize their family within one year of treatment (Hishikawa 2012).

This new study may provide even more insight as to why turmeric is proving so effective in treating neurologic disorders:

- The targeted (that is, pharmacologic) activation of endogenous NSCs [neural stem cells] has been shown to enhance self-repair and recovery of function in the adult brain in both stroke [13,14] and neurodegeneration (Hucklenbroich et al., 2014).

At certain concentrations, ar-turmerone was shown to increase NSC [neural stem cells] proliferation by up to 80%, without having any impact on cell death (BioMed Central, 2014).

Ar-turmerones ability to regenerate the brains stem cells has important implications in the event of stroke, dementia and neurodegeneration. This study was performed on rats in vivo and in vitro, and researchers concluded ar-turmerone is a prime candidate for developing a future drug to induce regeneration in neurodegenerative disorders/diseases.

Yet another reason to add this superfood to your arsenal!

Sources:

Aggarwal, Bharat B. and Kuzhuvelil B. Harikumar. Potential Therapeutic Effects of Curcumin, the Anti-inflammatory Agent, Against Neurodegenerative, Cardiovascular, Pulmonary, Metabolic, Autoimmune and Neoplastic Diseases. The International Journal of Biochemistry & Cell Biology, Volume 41, Issue 1, January 2009, Pages 4059.http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2637808/

BioMed Central. Turmeric compound boosts regeneration of brain stem cells. ScienceDaily, 25 September 2014. http://www.sciencedaily.com/releases/2014/09/140925205819.htm

More here:
New Study: Turmeric Compound Activates Regeneration of ...

Posted in New Mexico Stem Cells | Comments Off on New Study: Turmeric Compound Activates Regeneration of …

Stem Cell Treatments for Autism – LoveToKnow

Posted: January 17, 2015 at 7:57 am

Stem cell treatments for autism seek to address the pathogenic mechanisms of autism, which makes the approach unique among the various treatments for autistic disorders.

Stem cells are original cells that are able to change to mimic specialized cells in the body. The National Institutes of Health describes these primal cells as having the potential to replenish, heal and repair specialized cells. They have primary characteristics that make them distinct:

Types of stem cells include:

Research on stem cell treatments for autism is ongoing. Many therapies for pervasive developmental disorders address problems with the immune system, mitochondrial dysfunction and poor oxygen circulation to the brain. Treatments such as hyperbaric oxygen therapy and gluten free diets have varying results. Using stem cells is an approach that may address the source of the dysfunction in each system.

The Journal of Translational Medicine's article Stem Cell Therapy for Autism looks at two problems associated with autism that may be treated with stem cells, hypoperfusion and immune deregulation. The article proposes using CD34+ umbilical cord cells and mesenchymal cells.

Hypoperfusion (reduction of blood flow) can lead to hypoxia (concentration of oxygen falls below life sustaining levels) in the brain, which can lead to cell death and abnormal brain function. In theory, stem cell therapy may reverse hypoxia while activating the brain's "self repair mechanisms."

The connection between immune function and nervous system is strong. Stem cells may repair the immune system, which in theory would lead to improved neurological functioning.

A study from the Salk Institute for Biological Studies published in the science journal Nature explores the potential of using stem cells to repair circuits in individuals with neurological conditions such as:

Stem cells in the adult brain divide, and they have three potential paths to follow:

The stem cells require prompting from chemical signals to turn into specialized cells. Figuring out how to stimulate the chemical signals the stem cells to change into brain cells that are lost or damaged in neurological conditions.

Read more here:
Stem Cell Treatments for Autism - LoveToKnow

Posted in Mississippi Stem Cells | Comments Off on Stem Cell Treatments for Autism – LoveToKnow

Breast Cancer Stem Cell Research – University of Michigan …

Posted: January 17, 2015 at 7:57 am

In the fight against breast cancer, there is good news and bad news. The good news is that, since 1990, there has been a steady decline in the death rate from breast cancer. Earlier detection and better treatments are bringing hope to people with both early and advanced disease.

The bad news is that more than 40,000 people die from breast cancer every year in the United States alone. It is still the second-leading cause of deaths from cancer in women. The survival rate for those with advanced, metastatic breast cancer has not changed significantly for decades. In spite of more effective therapies, many patients still experience recurrences of breast cancer after treatment.

If you are having trouble viewing the video, watch it on our YouTube channel.

We believe that conventional therapies for advanced breast cancer are limited because they target the wrong cells. These therapies were designed to shrink cancers by killing all the cells in a tumor. We believe therapies could be more effective, and cause fewer side effects, if they were aimed specifically at a small group of cells within the tumor called cancer stem cells.

Breast cancer stem cells - the first to be identified in a solid tumor - were discovered in 2003 by scientists at the U-M Comprehensive Cancer Center. U-M scientists found that just a few cancer stem cells are responsible for the growth and spread of breast cancer. Unless the cancer stem cells are destroyed, the tumor is likely to come back and spread malignant cells to other parts of the body, a process called metastasis.

Because cancer stem cells are resistant to traditional chemotherapy and radiation, we need new treatments that can be targeted directly at these deadly cells. U-M Cancer Center scientists are studying breast cancer stem cells to learn more about them and to determine the type of therapy most likely to destroy the cells. The world's first clinical study of a treatment targeted at stem cells in breast cancer was conducted at the U-M Cancer Center and other clinical studies are currently in development.

All cells have a unique pattern of proteins, like a fingerprint, on their surface membranes. All breast cancer stem cells have a surface protein marker called CD44, along with very low levels or no levels of two markers called CD24 and lin. Using specialized equipment and techniques, scientists can separate cells with this combination of protein markers from millions of other cells in a tumor sample. U-M scientists also have identified a protein called ALDH, which is produced by cancer stem cells and can be detected in biopsies of patient tumors. Both genetic and non-genetic factors -- including age, radiation exposure, menstrual history and number of pregnancies -- are involved in the development of breast cancer.

If you are having trouble viewing the video, watch it on our YouTube channel.

Both genetic and non-genetic factors -- including age, radiation exposure, menstrual history and number of pregnancies -- are involved in the development of breast cancer.

For example, we know that women who inherit mutations in certain genes, especially BRCA1 and BRCA2, have a much higher risk of developing breast cancer. Mutations in HER2 and PTEN - genes involved in DNA repair and tumor suppression - are often present in aggressive breast cancers.

Read more:
Breast Cancer Stem Cell Research - University of Michigan ...

Posted in Michigan Stem Cells | Comments Off on Breast Cancer Stem Cell Research – University of Michigan …

Page 1,884«..1020..1,8831,8841,8851,886..1,8901,900..»